HIF1A and osteosarcoma: In vivo studies with microRNAs or HIF inhibiting drugs have shown that HIF inhibition reduces tumour growth [12, 13] and overcomes chemo-resistance of osteosarcoma [14]; conversely HIF-1α over-expression enhances tumourigenicity [15].